ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?

Jordan R. Hansford; Neevika Manoharan; Gauthier Bouche; Vijay Ramaswamy; Nada Jabado; Eric Bouffet

doi:10.1080/14728214.2024.2426649

ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?

Jordan R. Hansford, Neevika Manoharan, Gauthier Bouche, Vijay Ramaswamy, Nada Jabado, Eric Bouffet

Paediatric Neuro-Oncology

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Original language	English
Journal	Expert Opinion on Emerging Drugs
DOIs	https://doi.org/10.1080/14728214.2024.2426649
Publication status	Accepted/In press - 2024

Keywords

diffuse midline glioma
Dordaviprone
ONC201

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1080/14728214.2024.2426649

Cite this

@article{e6ccd05c9f2b47b9859aa68426855cb0,

title = "ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?",

keywords = "diffuse midline glioma, Dordaviprone, ONC201",

author = "Hansford, {Jordan R.} and Neevika Manoharan and Gauthier Bouche and Vijay Ramaswamy and Nada Jabado and Eric Bouffet",

year = "2024",

doi = "10.1080/14728214.2024.2426649",

language = "English",

journal = "Expert Opinion on Emerging Drugs",

issn = "1472-8214",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - ONC201 (Dordaviprone)

T2 - review of evidence to date in diffuse midline glioma, hope or hype?

AU - Hansford, Jordan R.

AU - Manoharan, Neevika

AU - Bouche, Gauthier

AU - Ramaswamy, Vijay

AU - Jabado, Nada

AU - Bouffet, Eric

PY - 2024

Y1 - 2024

KW - diffuse midline glioma

KW - Dordaviprone

KW - ONC201

UR - http://www.scopus.com/inward/record.url?scp=85210044904&partnerID=8YFLogxK

U2 - 10.1080/14728214.2024.2426649

DO - 10.1080/14728214.2024.2426649

M3 - Editorial

C2 - 39548664

AN - SCOPUS:85210044904

SN - 1472-8214

JO - Expert Opinion on Emerging Drugs

JF - Expert Opinion on Emerging Drugs

ER -

ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this